Funding your healthtech startup: alternatives & the role of your cap table
Mia de Bésche, Head of Investor Relations at Sting, will give a short overview of different early-stage funding options and what investors actually look for.
What does it take to attract venture capital?
How important is your cap table really?
And how much dilution is acceptable in early rounds?
Join us to get practical insights on funding strategies for healthtech founders, and bring your questions for the live Q&A.
Program
12.00–12.05
Introduction – Olof Berglund, Business Coach, Sting
12.05–13.00
Presentation – Mia de Bésche, Head of Investor Relations, Sting
13.00–13.30
Q&A session – Peter Löwenhielm, Business Adviser for Karolinska Institutet Innovation & Olof Berglund, Sting
As a participant in the webinar, you can also book an individual follow-up session to review your company’s financing plan with Peter Löwenhielm (KI Innovation) or Olof Berglund (Sting).
Please register for the webinar no later than 31 May.
Note: The webinar is part of the EU-funded project Circle of Lifescience.
